Globular adiponectin improves high glucose-suppressed endothelial progenitor cell function through endothelial nitric oxide synthase dependent mechanisms

Po Hsun Huang, Jia Shiong Chen, Hsiao Ya Tsai, Yung Hsiang Chen, Feng Yen Lin, Hsin Bang Leu, Tao Cheng Wu, Shing Jong Lin, Jaw Wen Chen

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Plasma levels of adiponectin, an adipose-specific protein with putative anti-atherogenic properties, could be down-regulated in obese and diabetic subjects. Recent insights suggest that the injured endothelial monolayer is regenerated by circulating endothelial progenitor cells (EPCs), but high glucose reduces number and functions of EPCs. Here, we tested the hypothesis that globular adiponectin can improve high glucose-suppressed EPC functions by restoration of endothelial nitric oxide synthase (eNOS) activity. Late EPCs isolated from healthy subjects appeared with cobblestone shape at 2-4. weeks. EPCs were incubated with high glucose (25. mM) and treatment with globular adiponectin for functional study. Migration and tube formation assays were used to evaluate the vasculogenetic capacity of EPCs. The activities of eNOS, Akt and concentrations of nitric oxide (NO) were also determined. Administration of globular adiponectin at physiological concentrations promoted EPC migration and tube formation, and dose-dependently upregulated phosphorylation of eNOS, Akt and augmented NO production. Chronic incubation of EPCs in high-glucose medium significantly impaired EPC function and induced cellular senescence, but these suppression effects were reversed by treatment with globular adiponectin. Globular adiponectin reversed high glucose-impaired EPC functions through NO- and p38 MAPK-related mechanisms. In addition, nude mice that received EPCs treated with adiponectin in high glucose medium showed a significant improvement in blood flow than those received normal saline and EPCs incubated in high glucose conditions. The administration of globular adiponectin improved high glucose-impaired EPC functions in vasculogenesis by restoration of eNOS activity. These beneficial effects may provide some novel rational to the vascular protective properties of adiponectin.

Original languageEnglish
Pages (from-to)109-119
Number of pages11
JournalJournal of Molecular and Cellular Cardiology
Volume51
Issue number1
DOIs
Publication statusPublished - Jul 2011

Fingerprint

Nitric Oxide Synthase Type III
Adiponectin
Glucose
Nitric Oxide
Endothelial Progenitor Cells
Cell Aging
p38 Mitogen-Activated Protein Kinases
Nude Mice
Cell Movement
Blood Vessels
Healthy Volunteers

Keywords

  • Adiponectin
  • Endothelial progenitor cell
  • Hyperglycemia
  • Mitogen-activated protein kinase
  • Nitric oxide

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Globular adiponectin improves high glucose-suppressed endothelial progenitor cell function through endothelial nitric oxide synthase dependent mechanisms. / Huang, Po Hsun; Chen, Jia Shiong; Tsai, Hsiao Ya; Chen, Yung Hsiang; Lin, Feng Yen; Leu, Hsin Bang; Wu, Tao Cheng; Lin, Shing Jong; Chen, Jaw Wen.

In: Journal of Molecular and Cellular Cardiology, Vol. 51, No. 1, 07.2011, p. 109-119.

Research output: Contribution to journalArticle

Huang, Po Hsun ; Chen, Jia Shiong ; Tsai, Hsiao Ya ; Chen, Yung Hsiang ; Lin, Feng Yen ; Leu, Hsin Bang ; Wu, Tao Cheng ; Lin, Shing Jong ; Chen, Jaw Wen. / Globular adiponectin improves high glucose-suppressed endothelial progenitor cell function through endothelial nitric oxide synthase dependent mechanisms. In: Journal of Molecular and Cellular Cardiology. 2011 ; Vol. 51, No. 1. pp. 109-119.
@article{2697847527b24e7e8863b58b975a9100,
title = "Globular adiponectin improves high glucose-suppressed endothelial progenitor cell function through endothelial nitric oxide synthase dependent mechanisms",
abstract = "Plasma levels of adiponectin, an adipose-specific protein with putative anti-atherogenic properties, could be down-regulated in obese and diabetic subjects. Recent insights suggest that the injured endothelial monolayer is regenerated by circulating endothelial progenitor cells (EPCs), but high glucose reduces number and functions of EPCs. Here, we tested the hypothesis that globular adiponectin can improve high glucose-suppressed EPC functions by restoration of endothelial nitric oxide synthase (eNOS) activity. Late EPCs isolated from healthy subjects appeared with cobblestone shape at 2-4. weeks. EPCs were incubated with high glucose (25. mM) and treatment with globular adiponectin for functional study. Migration and tube formation assays were used to evaluate the vasculogenetic capacity of EPCs. The activities of eNOS, Akt and concentrations of nitric oxide (NO) were also determined. Administration of globular adiponectin at physiological concentrations promoted EPC migration and tube formation, and dose-dependently upregulated phosphorylation of eNOS, Akt and augmented NO production. Chronic incubation of EPCs in high-glucose medium significantly impaired EPC function and induced cellular senescence, but these suppression effects were reversed by treatment with globular adiponectin. Globular adiponectin reversed high glucose-impaired EPC functions through NO- and p38 MAPK-related mechanisms. In addition, nude mice that received EPCs treated with adiponectin in high glucose medium showed a significant improvement in blood flow than those received normal saline and EPCs incubated in high glucose conditions. The administration of globular adiponectin improved high glucose-impaired EPC functions in vasculogenesis by restoration of eNOS activity. These beneficial effects may provide some novel rational to the vascular protective properties of adiponectin.",
keywords = "Adiponectin, Endothelial progenitor cell, Hyperglycemia, Mitogen-activated protein kinase, Nitric oxide",
author = "Huang, {Po Hsun} and Chen, {Jia Shiong} and Tsai, {Hsiao Ya} and Chen, {Yung Hsiang} and Lin, {Feng Yen} and Leu, {Hsin Bang} and Wu, {Tao Cheng} and Lin, {Shing Jong} and Chen, {Jaw Wen}",
year = "2011",
month = "7",
doi = "10.1016/j.yjmcc.2011.03.008",
language = "English",
volume = "51",
pages = "109--119",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Globular adiponectin improves high glucose-suppressed endothelial progenitor cell function through endothelial nitric oxide synthase dependent mechanisms

AU - Huang, Po Hsun

AU - Chen, Jia Shiong

AU - Tsai, Hsiao Ya

AU - Chen, Yung Hsiang

AU - Lin, Feng Yen

AU - Leu, Hsin Bang

AU - Wu, Tao Cheng

AU - Lin, Shing Jong

AU - Chen, Jaw Wen

PY - 2011/7

Y1 - 2011/7

N2 - Plasma levels of adiponectin, an adipose-specific protein with putative anti-atherogenic properties, could be down-regulated in obese and diabetic subjects. Recent insights suggest that the injured endothelial monolayer is regenerated by circulating endothelial progenitor cells (EPCs), but high glucose reduces number and functions of EPCs. Here, we tested the hypothesis that globular adiponectin can improve high glucose-suppressed EPC functions by restoration of endothelial nitric oxide synthase (eNOS) activity. Late EPCs isolated from healthy subjects appeared with cobblestone shape at 2-4. weeks. EPCs were incubated with high glucose (25. mM) and treatment with globular adiponectin for functional study. Migration and tube formation assays were used to evaluate the vasculogenetic capacity of EPCs. The activities of eNOS, Akt and concentrations of nitric oxide (NO) were also determined. Administration of globular adiponectin at physiological concentrations promoted EPC migration and tube formation, and dose-dependently upregulated phosphorylation of eNOS, Akt and augmented NO production. Chronic incubation of EPCs in high-glucose medium significantly impaired EPC function and induced cellular senescence, but these suppression effects were reversed by treatment with globular adiponectin. Globular adiponectin reversed high glucose-impaired EPC functions through NO- and p38 MAPK-related mechanisms. In addition, nude mice that received EPCs treated with adiponectin in high glucose medium showed a significant improvement in blood flow than those received normal saline and EPCs incubated in high glucose conditions. The administration of globular adiponectin improved high glucose-impaired EPC functions in vasculogenesis by restoration of eNOS activity. These beneficial effects may provide some novel rational to the vascular protective properties of adiponectin.

AB - Plasma levels of adiponectin, an adipose-specific protein with putative anti-atherogenic properties, could be down-regulated in obese and diabetic subjects. Recent insights suggest that the injured endothelial monolayer is regenerated by circulating endothelial progenitor cells (EPCs), but high glucose reduces number and functions of EPCs. Here, we tested the hypothesis that globular adiponectin can improve high glucose-suppressed EPC functions by restoration of endothelial nitric oxide synthase (eNOS) activity. Late EPCs isolated from healthy subjects appeared with cobblestone shape at 2-4. weeks. EPCs were incubated with high glucose (25. mM) and treatment with globular adiponectin for functional study. Migration and tube formation assays were used to evaluate the vasculogenetic capacity of EPCs. The activities of eNOS, Akt and concentrations of nitric oxide (NO) were also determined. Administration of globular adiponectin at physiological concentrations promoted EPC migration and tube formation, and dose-dependently upregulated phosphorylation of eNOS, Akt and augmented NO production. Chronic incubation of EPCs in high-glucose medium significantly impaired EPC function and induced cellular senescence, but these suppression effects were reversed by treatment with globular adiponectin. Globular adiponectin reversed high glucose-impaired EPC functions through NO- and p38 MAPK-related mechanisms. In addition, nude mice that received EPCs treated with adiponectin in high glucose medium showed a significant improvement in blood flow than those received normal saline and EPCs incubated in high glucose conditions. The administration of globular adiponectin improved high glucose-impaired EPC functions in vasculogenesis by restoration of eNOS activity. These beneficial effects may provide some novel rational to the vascular protective properties of adiponectin.

KW - Adiponectin

KW - Endothelial progenitor cell

KW - Hyperglycemia

KW - Mitogen-activated protein kinase

KW - Nitric oxide

UR - http://www.scopus.com/inward/record.url?scp=79956327626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956327626&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2011.03.008

DO - 10.1016/j.yjmcc.2011.03.008

M3 - Article

C2 - 21439968

AN - SCOPUS:79956327626

VL - 51

SP - 109

EP - 119

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 1

ER -